Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evidence for Biological Age Acceleration and Telomere Shortening in COVID-19 Survivors
Alessia Mongelli, Veronica Barbi, Michela Gottardi Zamperla, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 6151-6151
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

The landscape of aging
Yusheng Cai, Wei Song, Jiaming Li, et al.
Science China Life Sciences (2022) Vol. 65, Iss. 12, pp. 2354-2454
Open Access | Times Cited: 227
Biomarkers of aging
Hainan Bao, Jiani Cao, Mengting Chen, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 5, pp. 893-1066
Open Access | Times Cited: 184
Accelerated biological aging in COVID-19 patients
Xue Cao, Wenjuan Li, Ting Wang, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 170
Long COVID and the cardiovascular system—elucidating causes and cellular mechanisms in order to develop targeted diagnostic and therapeutic strategies: a joint Scientific Statement of the ESC Working Groups on Cellular Biology of the Heart and Myocardial and Pericardial Diseases
Mariann Gyöngyösi, Pilar Alcaide, Folkert W. Asselbergs, et al.
Cardiovascular Research (2022) Vol. 119, Iss. 2, pp. 336-356
Open Access | Times Cited: 122
Association between COVID‐19 and telomere length: A bidirectional Mendelian randomization study
Danqi Huang, Siqi Lin, Junting He, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 11, pp. 5345-5353
Open Access | Times Cited: 67
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review
Sy Duong‐Quy, Thu Vo-Pham-Minh, Quynh Tran-Xuan, et al.
Pulmonary Therapy (2023) Vol. 9, Iss. 3, pp. 295-307
Open Access | Times Cited: 46
How to Slow down the Ticking Clock: Age-Associated Epigenetic Alterations and Related Interventions to Extend Life Span
Anne-Marie Galow, Shahaf Peleg
Cells (2022) Vol. 11, Iss. 3, pp. 468-468
Open Access | Times Cited: 41
Longitudinal Study of DNA Methylation and Epigenetic Clocks Prior to and Following Test-Confirmed COVID-19 and mRNA Vaccination
Alina P.S. Pang, Albert T. Higgins-Chen, Florence Comite, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 34
Nutraceuticals and Dietary Supplements for Older Adults with Long COVID-19
Matteo Tosato, Francesca Ciciarello, Maria Beatrice Zazzara, et al.
Clinics in Geriatric Medicine (2022) Vol. 38, Iss. 3, pp. 565-591
Open Access | Times Cited: 33
Immunosenescence in atherosclerosis: A role for chronic viral infections
Atefe Ghamar Talepoor, Mehrnoosh Doroudchi
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 32
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review
Laura Bergantini, Alessandro Mainardi, Miriana d’Alessandro, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
COVID-19 lung disease shares driver AT2 cytopathic features with Idiopathic pulmonary fibrosis
Saptarshi Sinha, Vanessa Castillo, Celia R. Espinoza, et al.
EBioMedicine (2022) Vol. 82, pp. 104185-104185
Open Access | Times Cited: 31
Potential for Early Noninvasive COVID-19 Detection Using Electronic-Nose Technologies and Disease-Specific VOC Metabolic Biomarkers
A. D. Wilson, Lisa Beth Forse
Sensors (2023) Vol. 23, Iss. 6, pp. 2887-2887
Open Access | Times Cited: 20
Coronary “Microvascular Dysfunction”: Evolving Understanding of Pathophysiology, Clinical Implications, and Potential Therapeutics
Chun Yeung Kei, Kuljit Singh, Rustem Dautov, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11287-11287
Open Access | Times Cited: 18
Exploring DNA methylation, telomere length, mitochondrial DNA, and immune function in patients with Long-COVID
Andrea Polli, Lode Godderis, Dries S. Martens, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Epigenetic Clocks Are Not Accelerated in COVID-19 Patients
Julia Franzen, Selina Nüchtern, Vithurithra Tharmapalan, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9306-9306
Open Access | Times Cited: 39
EWAS of post-COVID-19 patients shows methylation differences in the immune-response associated gene, IFI44L, three months after COVID-19 infection
Yunsung Lee, Espen Riskedal, Karl Trygve Kalleberg, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 22
Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
Andrew G. Ewing, Špela Šalamon, Etheresia Pretorius, et al.
Medical Review (2024) Vol. 5, Iss. 1, pp. 66-75
Open Access | Times Cited: 4
Impact of computational approaches in the fight against COVID-19: an AI guided review of 17 000 studies
Francesco Napolitano, Xiaopeng Xu, Xin Gao
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Open Access | Times Cited: 30
SARS-CoV-2 and the Nucleus
Mengqi Chen, Yue Ma, Wakam Chang
International Journal of Biological Sciences (2022) Vol. 18, Iss. 12, pp. 4731-4743
Open Access | Times Cited: 21
Impairment of Anti-Aggregatory Responses to Nitric Oxide and Prostacyclin: Mechanisms and Clinical Implications in Cardiovascular Disease
Yuliy Y. Chirkov, Thanh H. Nguyen, John D. Horowitz
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1042-1042
Open Access | Times Cited: 20
The Challenge of Long COVID-19 Management: From Disease Molecular Hallmarks to the Proposal of Exercise as Therapy
R. Scurati, Nadia Papini, Paola Giussani, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12311-12311
Open Access | Times Cited: 20
Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
Fabio Angeli, Paolo Verdecchia, Antonella Balestrino, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 1, pp. 15-15
Open Access | Times Cited: 18
S1 guidelines for the management of postviral conditions using the example of post-COVID-19
Susanne Rabady, Kathryn Hoffmann, Martin Aigner, et al.
Wiener klinische Wochenschrift (2023) Vol. 135, Iss. S4, pp. 525-598
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top